RENAISSANCE TECHNOLOGIES LLC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in LXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,704,800
+$208,020 QoQ
Shares Held
1,127,000
-29.6% QoQ
Ownership
0.253%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 149 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. LXRX ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in LXRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,704,800 | 1,127,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,496,780 | 1,600,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $302,742 | 263,254 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $394,740 | 292,400 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $37,844 | 51,141 | Shares | Sole | 2025-02-13 | |
| 2023-12-31 | $630,627 | 412,175 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $296,757 | 272,255 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $641,216 | 263,875 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $751,174 | 393,285 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,155,300 | 481,375 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $185,541 | 88,776 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $274,367 | 59,775 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,834,251 | 312,479 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,402,828 | 994,979 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,350,988 | 1,632,631 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,760,406 | 1,880,203 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,249,866 | 1,666,598 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||